COMMUNIQUÉS West-GlobeNewswire

Orion Corporation: Managers' transactions - Eero Karvonen kuolinpesä

08/05/2018 - 15:31

ORION CORPORATION MANAGERS' TRANSACTIONS 8 MAY 2018 at 16.30 EETS Orion Corporation: Managers' transactions - Eero Karvonen kuolinpesä Orion Corporation has received the following disclosure under Market Abuse [...]

Arch Biopartners Completes Pre-IND Meeting with U.S. FDA on LSALT Peptide for Preventing Acute Kidney Injury in Cardiac Surgery Patients

08/05/2018 - 15:25

TORONTO, May 08, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (Arch or the Company) (TSX Venture:ARCH) (OTCBB: ACHFF ), announced today it completed a successful pre-IND (Investigational New Drug) meeting via [...]

Psychological Effects of Ovarian Cancer Often Overlooked and Can Have a Significant Impact on Patients

08/05/2018 - 15:19

79% of patients felt uncomfortable raising psychological and emotional concerns during their consultations 1 Disease recurrence is of greatest concern for ovarian cancer patients, but poorly addressed, with 53% of [...]

Vistin Pharma ASA : Energy trading business to commence operations

08/05/2018 - 15:18

Oslo, Norway, 8 May 2018 Reference is made to the announcements from Vistin Pharma ASA on 16 March and 22 March regarding the development of a new business area within energy trading. At the annual general meeting held [...]

EY Canada Health Practice and VitalHub Sign Joint Marketing Agreement for WellLinc

08/05/2018 - 15:15

TORONTO, May 08, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) is pleased to announce that Ernst & Young LLP (“EY Canada”) has signed a Marketing Agreement with VitalHub, who is [...]

Vistin Pharma ASA : Minutes from the annual general meeting 2018

08/05/2018 - 15:05

Vistin Pharma ASA (OSE: VISTIN), please find attached the minutes from the annual general meeting held on 8 May 2018. All matters were resolved as proposed in the call for the annual general meeting. For further [...]

Aquinox Pharmaceuticals Announces First Quarter 2018 Financial Results

08/05/2018 - 15:05

VANCOUVER, British Columbia, May 08, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to [...]

New Preclinical Data for Novel Immunotherapy Bispecific Candidate ALG.APV-527 Presented by Aptevo Therapeutics and Alligator Bioscience at Prominent Industry Conferences

08/05/2018 - 15:02

ALG.APV-527 is Designed to Strategically Target and Engage the Immune System for the Potential Treatment of Multiple Solid Tumor Indications SEATTLE and LUND, Sweden, May 08, 2018 (GLOBE NEWSWIRE) -- Aptevo Therapeutics [...]

Mayo Regional Hospital Selects Cerner CommunityWorks

08/05/2018 - 15:01

DOVER-FOXCROFT, Maine, May 08, 2018 (GLOBE NEWSWIRE) -- Mayo Regional Hospital has selected Cerner, a global leader in health care technology, to implement a new integrated electronic health record (EHR) and revenue [...]

BLVD Centers Announces Plan to List on the Canadian Securities Exchange as Part of its Plan to Move into the US Marijuana Market

08/05/2018 - 15:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES LOS ANGELES, May 08, 2018 (GLOBE NEWSWIRE) -- BLVD Centers Corporation (the “ Company ”) announced today that it has [...]

Lexington Engages with Major Canadian University and Provides Clinical Trial Update

08/05/2018 - 15:00

Company commences HeartSentry clinical research collaboration with University of British Columbia VANCOUVER, British Columbia, May 08, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “ [...]

Klaus Bjerrum appointed new EVP of the Natural Colors Division, Chr. Hansen Holding A/S

08/05/2018 - 14:57

Company announcement No. 09/2018 Attachment No 09 2018 New EVP Natural Colors Division

Helsinn Group announces the launch of the IV formulation of AKYNZEO® (fosnetupitant/palonosetron) in the United States

08/05/2018 - 14:31

Helsinn Group announces the launch of the IV formulation of AKYNZEO ® (fosnetupitant/palonosetron) in the United States Lugano, Switzerland, and Iselin, NJ, United States, May 8, 2018 - Helsinn, a Swiss pharmaceutical [...]

Trading in Novo Nordisk shares by board members, executives and associated persons on 7 May 2018

08/05/2018 - 14:30

Bagsværd, Denmark, 8 May 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of [...]

Yield10 Researchers Publish Research in Plant Science Showing that Novel Transcription Factors Represent a Promising Approach for Increasing Crop Productivity

08/05/2018 - 14:30

WOBURN, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, today [...]

Zecotek Prepares to Open LFS Crystal Production Facility in China June 2018

08/05/2018 - 14:30

VANCOUVER, B.C., May 08, 2018 (GLOBE NEWSWIRE) -- Zecotek Photonics Inc. (“Zecotek” or the “Company”) (TSX-V: ZMS ) (Frankfurt: W1I ) (OTCPK:ZMSPF), a developer of leading-edge photonics technologies for healthcare, [...]

Precision Therapeutics to Hold Business Update Conference Call on May 15, 2018

08/05/2018 - 14:30

MINNEAPOLIS, May 08, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]

Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

08/05/2018 - 14:30

WARREN, N.J., May 08, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH ) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that, following the receipt of [...]

Rockwell Medical Update on Calcitriol New Manufacturing Submission to FDA

08/05/2018 - 14:30

WIXOM, Mich., May 08, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI ), today provided an update on its new manufacturing submission for its Calcitriol vitamin D injection, stating that the FDA has [...]